tirzepatide ruling january 2025 Leads Pharma Growth in with $11.4B in Sales | Brian K. Buntz posted on the topic Lilly asks to join lawsuit

Description

For people tired of injections, this could provide a meaningful alternative to cycling between injectable options

Distinct Approved Uses While both medications share some similarities, they differ significantly in their additional approvals and benefits

The BBB listing shows their business is based in Houston, Texas, categorized under "weight loss." Trustpilot analysis The Trustpilot profile tells an interesting story when you look at the distribution: 5 stars: 62% (approximately 1,900 reviews) 4 stars: 10% (approximately 295 reviews) 3 stars: 5% (approximately 152 reviews) 2 stars: 5% (approximately 160 reviews) 1 star: 18% (approximately 558 reviews) That 18% one-star rate is high

In clinical trials, tirzepatide showed a low rate of injection-site reactions, with most patients experiencing either no sensation or mild, brief tingling that resolves within minutes